首页> 外文期刊>Biomaterials >The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats
【24h】

The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats

机译:自体富集骨髓间充质干细胞在长期缺乏雌激素的山羊中增强骨质疏松性骨缺损的修复

获取原文
获取原文并翻译 | 示例
           

摘要

Bone defects are common in elderly patients suffering from osteoporosis. Current methods of bone defect treatment for osteoporosis are not always satisfactory. In this study, we demonstrated that bone marrow mesenchymal stem cells (MSCs) harvested from goats with long-term estrogen deficiencies exhibited a lower proliferation rate and decreased osteogenic capacity, which are critical obstacles for bone defect repair in the elderly. However, by combining autologous enriched bone marrow mesenchymal stem cells with porous β-TCP, we successfully repaired critical-sized bone defects in the medial femoral condyle of the osteoporotic goats. Both micro-CT images and histomorphometry analysis illustrated improved bone formation following the enriched MSC therapy. Thus, we proposed autologous enriched bone marrow mesenchymal stem cells as a quick, safe therapeutic strategy to treat osteoporotic bone defects.
机译:骨缺损在患有骨质疏松症的老年患者中很常见。当前用于骨质疏松症的骨缺损治疗方法并不总是令人满意的。在这项研究中,我们证明了从长期雌激素缺乏的山羊收获的骨髓间充质干细胞(MSC)表现出较低的增殖率和成骨能力下降,这是老年人骨缺损修复的关键障碍。但是,通过将自体富集的骨髓间充质干细胞与多孔β-TCP结合,我们成功地修复了骨质疏松山羊内侧股骨critical的临界大小的骨缺损。显微CT图像和组织形态计量学分析均显示了丰富的MSC治疗后改善的骨形成。因此,我们提出了自体富集的骨髓间充质干细胞作为治疗骨质疏松性骨缺损的一种快速,安全的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号